UnlockSangamo seeks court validation for stock amendment
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sangamo Therapeutics Inc (SGMO)
NASDAQ
Currency in USD
Disclaimer
0.8022
+0.0212(+2.56%)
Closed
After Hours
0.8095+0.0073(+0.91%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.7500
0.8100
52 wk Range
0.2911
1.4800
SGMO Scorecard
Full Analysis
Quickly burning through cash
"Sangamo Therapeutics Inc stock price live, this page displays NASDAQ SGMO stock exchange data. View the SGMO premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Sangamo Therapeutics Inc real time stock price chart below.
What Is the Sangamo Therapeutics Inc Stock Price Today?
The Sangamo Therapeutics Inc stock price today is 0.8022.
What Is the Stock Symbol for Sangamo Therapeutics Inc?
The stock symbol for Sangamo Therapeutics Inc is ""SGMO.""
What Stock Exchange Does Sangamo Therapeutics Inc Trade On?
Sangamo Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Sangamo Therapeutics Inc a Good Stock to Buy?
Determining whether Sangamo Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SGMO quote. (ISIN: US8006771062)"
What Is the Sangamo Therapeutics Inc Stock Price Today?
The Sangamo Therapeutics Inc stock price today is 0.8022.
What Is the Stock Symbol for Sangamo Therapeutics Inc?
The stock symbol for Sangamo Therapeutics Inc is ""SGMO.""
What Stock Exchange Does Sangamo Therapeutics Inc Trade On?
Sangamo Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Sangamo Therapeutics Inc a Good Stock to Buy?
Determining whether Sangamo Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SGMO quote. (ISIN: US8006771062)"
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.75000.8100
52 wk Range
0.29111.4800
SGMO Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Price Target
3.8000
Upside
+373.6973%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales decline in the current year
Sangamo Therapeutics Inc Company Profile
Sangamo Therapeutics, Inc., a clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States. The company’s clinical-stage product candidates are ST-920, a gene therapy product candidate, which is in Phase 1/2 clinical study for the treatment of Fabry disease; TX200, a chimeric antigen receptor engineered regulatory T cell (CAR-Treg) therapy product candidate that is in Phase 1/2 clinical study for the prevention of immune-mediated rejection in HLA-A2 mismatched kidney transplantation; SB-525, a gene therapy product candidate, which is in Phase 3 clinical trial for the treatment of moderately severe to severe hemophilia A; BIVV003, a zinc finger nuclease gene-edited cell therapy product candidate that is in Phase 1/2 PRECIZN-1 clinical study for the treatment of sickle cell disease. Its preclinical development products focus on CAR-Treg cell therapies for autoimmune disorders and genome engineering for neurological diseases. Sangamo Therapeutics, Inc. has collaborative and strategic partnerships with Biogen MA, Inc.; Kite Pharma, Inc.; Pfizer Inc.; Sanofi S.A.; Novartis Institutes for BioMedical Research, Inc.; Shire International GmbH; Dow AgroSciences LLC; Sigma-Aldrich Corporation; Genentech, Inc.; Open Monoclonal Technology, Inc.; and California Institute for Regenerative Medicine. The company was formerly known as Sangamo BioSciences, Inc. and changed its name to Sangamo Therapeutics, Inc. in January 2017. Sangamo Therapeutics, Inc. was incorporated in 1995 and is headquartered in Richmond, California.
Compare SGMO to Peers and Sector
Metrics to compare | SGMO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSGMOPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.7x | −1.9x | −0.6x | |
PEG Ratio | 0.05 | −0.06 | 0.00 | |
Price/Book | 7.1x | 2.3x | 2.6x | |
Price / LTM Sales | 13.6x | 8.6x | 3.2x | |
Upside (Analyst Target) | 274.0% | 382.2% | 46.5% | |
Fair Value Upside | Unlock | 25.2% | 6.6% | Unlock |
People Also Watch
FAQ
What Is the Sangamo Therapeutics (SGMO) Stock Price Today?
The Sangamo Therapeutics stock price today is 0.8022
What Stock Exchange Does Sangamo Therapeutics Trade On?
Sangamo Therapeutics is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for Sangamo Therapeutics?
The stock symbol for Sangamo Therapeutics is "SGMO."
What Is the Sangamo Therapeutics Market Cap?
As of today, Sangamo Therapeutics market cap is 167.03M.
What is Sangamo Therapeutics Earnings Per Share?
The Sangamo Therapeutics EPS is -1.34.
What Is the Next Sangamo Therapeutics Earnings Date?
Sangamo Therapeutics will release its next earnings report on Oct 30, 2024.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.